JDP Therapeutics, Inc. — Form D
JDP Therapeutics, Inc. of LANSDALE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2013-03-12. The offering totals $3.0M, of which $200K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-03-12
- Form: D
- Accession: 0001488520-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $3.0M
- Amount sold: $200K
- Remaining: $2.8M
- Minimum investment: $25K
- Investors: 4
- Date of first sale: 2013-02-15
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-193150
Issuer
- Name: JDP Therapeutics, Inc.
- CIK: 0001488520
- Entity type: Corporation
- Jurisdiction: PENNSYLVANIA
- Incorporated: 2008
- Address: 823 JAYS DRIVE, LANSDALE, PA, 19446
- Phone: (215) 661-8557
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| John M Morrash | Director | Danboro, PA |
| Joshua M Tarnoff | Director | Radnor, PA |
| Joshua M Tarnoff | Executive Officer | Radnor, PA |
| Jonathan H Black | Director | Lansdale, PA |
| Jie Du | Director | Lansdale, PA |
| Jie Du | Executive Officer | Lansdale, PA |
| Christopher M Cashman | Director | Bedford, MA |
Other filings by this issuer (4)
More